Globally, the rise of more informed healthcare consumers, new technologies, and ubiquity of data and analytics
continues to blur the traditional boundaries between therapeutics, medical technologies, consumer devices and
information technology (IT). This rapidly evolving superfluid market is putting pressure on the life sciences
(LS) companies to change their business models and personalize their products and services. The question life
sciences companies must address urgently is how they should be preparing themselves for the coming future.
BioAsia 2020 explores the capabilities that Life sciences companies should invest in Today to thrive and
create value Tomorrow.
Worldwide Chairman - Pharma, EVP & CSO, Johnson & Johnson, USA (2017)
Dr. Vas Narasimhan
Global Head of Drug Dev. & CMO, Novartis, Switzerland (2017)
Dr. Udit Batra
Member of the Executive Board CEO Life Science, Merck, Germany
Mrs. Kiran Mazumdar Shaw
Chairman & Managing Director, Biocon Ltd.
Mr. Satish Reddy
Chairman, Dr. Reddy's Laboratories Ltd.
Dr. Pankaj Patel
CMD, Zydus Cadila (2016)
BioAsia 2020 will bring together the global industry leaders, researchers,
policy makers, innovators, and investors together on one platform to deliberate on adapting business models today to catering to the changes of tomorrow.
High Profile Speakers
Advancing global health through affordable innovation